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STUDY PROTOCOL Open Access
Protocol for two-arm pragmatic cluster
randomized hybrid implementation-
effectiveness trial comparing two education
strategies for improving the uptake of
noninvasive ventilation in patients with
severe COPD exacerbation
Mihaela S. Stefan1,2*, Penelope S. Pekow1,3, Christopher M. Shea4, Ashley M. Hughes5, Nicholas S. Hill6,
Jay S. Steingrub7 and Peter K. Lindenauer1,2,8
Abstract
Background: COPD is the fourth leading cause of death in the US, and COPD exacerbations result in approximately
700,000 hospitalizations annually. Patients with acute respiratory failure due to severe COPD exacerbation are
treated with invasive (IMV) or noninvasive mechanical ventilation (NIV). Although IMV reverses hypercapnia/hypoxia,
it causes significant morbidity and mortality. There is strong evidence that patients treated with NIV have better
outcomes, and NIV is recommended as first line therapy in these patients. Yet, several studies have demonstrated
substantial variation in the use of NIV across hospitals, leading to preventable morbidity and mortality. Through a
series of mixed-methods studies, we have found that successful implementation of NIV requires physicians,
respiratory therapists (RTs), and nurses to communicate and collaborate effectively, suggesting that efforts to
increase the use of NIV in COPD need to account for the complex and interdisciplinary nature of NIV delivery and
the need for team coordination. Therefore, we propose to compare two educational strategies: online education
(OLE) and interprofessional education (IPE) which targets complex team-based care in NIV delivery.
(Continued on next page)
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Methods and design: Twenty hospitals with low baseline rates of NIV use will be randomized to either the OLE or
IPE study arm. The primary outcome of the trial is change in the hospital rate of NIV use among patients with
COPD requiring ventilatory support. In aim 1, we will compare the uptake change over time of NIV use among
patients with COPD in hospitals enrolled in the two arms. In aim 2, we will explore mediators’ role (respiratory
therapist autonomy and team functionality) on the relationship between the implementation strategies and
implementation effectiveness. Finally, in aim 3, through interviews with providers, we will assess acceptability and
feasibility of the educational training.
Discussions: This study will be among the first to carefully test the impact of IPE in the inpatient setting. This work
promises to change practice by offering approaches to facilitate greater uptake of NIV and may generalize to other
interventions directed to seriously-ill patients.
Trial registration: Name of registry: ClinicalTrials.gov
Trial registration number: NCT04206735
Date of Registration: December 20, 2019
Keywords: COPD, Noninvasive ventilation, Interprofessional training, Education, Teamwork, Implementation
strategies
Background
Chronic obstructive pulmonary disease (COPD) is the
fourth leading cause of death in the US, and COPD exacer-
bations result in approximately 700,000 hospitalizations
annually [1, 2]. Patients who do not respond to pharmaco-
therapy are placed on invasive (IMV) or noninvasive mech-
anical ventilation (NIV). While invasive mechanical
ventilation (IMV) administered through an endotracheal
tube is an effective method of treating acute respiratory, it
requires treatment in an intensive care unit, and places pa-
tients at risk for a wide range of complications, including
ventilator-associated pneumonia. NIV (continuous positive
airway pressure, CPAP or Bilevel positive airway pressure,
BIPAP) provides positive pressure ventilation via a face
mask without the need for intubation. Multiple randomized
controlled trials [3, 4], meta-analysis [5, 6], and analyses of
real-world data [7, 8] have demonstrated that treatment
with NIV, when added to usual care, reduces the risk of in-
tubation, lowers the incidence of ventilator associated
Contributions to the literature
 This will be among the first studies to analyze the
effectiveness and feasibility of implementing
interprofessional education alongside a standard of care
initiative (e.g., NIV use in COPD exacerbations) as a
continuing educational course onsite at hospitals.
 This study will add to the literature regarding the role of
interprofessional education on team functionality for a
standard of care initiative that can impact the use of NIV,
length of patient stay, and mortality for COPD patients.
complications, and results in better short-term survival.
Based on this evidence, NIV receives a grade A recommen-
dation in current Global Initiative for Chronic Obstructive
Lung Disease (GOLD) guidelines [9]. Furthermore, the
European Respiratory Society and American Thoracic Soci-
ety joint guidelines [10] as well as British Thoracic Society
guidelines [11] make a strong recommendation for the use
of NIV as a first-line treatment for patients with COPD ex-
acerbation and acute respiratory failure.
Although the evidence supporting the use of NIV is
compelling, prior research has demonstrated substantial
variation in the use of NIV in routine clinical settings,
highlighting a persistent gap in NIV adoption. In a re-
cent study of more than 77,500 patients with COPD
cared for at 400 US hospitals, median hospital percent-
age of NIV use among ventilated patients was 75.1%
(range 9.2–94.1%) and the bottom 20% of hospitals of-
fered a trial of NIV to less than half of ventilated pa-
tients [12]. More importantly, institutions with higher
rates of NIV had lower IMV use and better clinical out-
comes. Thus, low hospital rates of NIV in patients ad-
mitted for severe COPD represents an evidence practice
gap and a missed opportunity to improve the outcomes
among this vulnerable population. Appropriate delivery
of NIV is a complex, multicomponent intervention that
requires timely recognition, and effective communica-
tion, and coordination across multiple disciplines. Figure
1 depicts the flow for a patient who comes to the emer-
gency department with severe COPD exacerbation and
each clinician’s responsibilities in the process of NIV ini-
tiation and monitoring. Only few studies have tested
strategies for supporting NIV implementation. A single
site, before-after study from Canada found that multidis-
ciplinary guidelines for the use of NIV in patients with
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acute respiratory failure (ARF) were associated with
greater NIV utilization but included only patients in the
intensive care unit [13].
For this study, we used the intervention mapping process
model to develop and select implementation strategies to
increase the uptake of NIV [14]. Figure 2 summarizes the
steps in the development of our implementation strategy to
increase the use of NIV in severe COPD exacerbation. In
step 1 (formative evaluation), we conducted semi-
structured interviews with key informants in a sample of
hospitals with high rates of NIV and good COPD outcomes
(low mortality and NIV failure rates). The analysis of the
Fig. 1 Clinician roles in management of patients with severe COPD in need for ventilation. Key: ED = Emergency Department, MD = Physician, RT
= Respiratory Therapist, NIV = Noninvasive Ventilation, IMV = Invasive Ventilation, RT = Respiratory Therapist
Fig. 2 Step-by-step development and evaluation of the implementation strategy. Key: NIV = Noninvasive Ventilation, COPD = Chronic Obstructive
Pulmonary Disease, RT = Respiratory Therapist, TDF = Theoretical Domains Framework, ERIC = Expert Recommendations for Implementing
Change, RCT = Randomized Control Trial
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interviews revealed 3 different professional identities and
roles in NIV delivery: physicians, respiratory therapists
(RTs), and nurses. Although several clinicians’ tasks are dis-
tinct, Fig. 1 shows the connections between physicians,
nurses, and RTs indicating the need for coordination to en-
sure optimal patient outcomes. The three groups encounter
significant professional boundary issues with regards to
their work responsibilities and priorities. For example,
nurses were concerned about patient’s inability to eat or
take medications while on NIV. RTs considered that nurses
do not have a good understanding of the vital role of NIV.
However, the two professions agreed that when there was a
shared understanding of the treatment plan and when the
concerns from both sides were openly addressed, the col-
laboration was considerably improved. RTs perceived
themselves as experts in initiating and managing NIV; in
some institutions, there was a strained relation between the
RTs and physicians, with RTs complaining about a lack of
autonomy and the need to wait for physicians when NIV
was immediately indicated. We identified the following
contextual factors and strategies associated with successful
NIV implementation: provider buy-in, respiratory thera-
pists (RT) autonomy to deliver NIV independently, inter-
disciplinary teamwork, collegial, trusting relationships
between RTs, physicians, and nurses, and ongoing staff
education [15].
In step 2, we organized the specific types of determi-
nants that influence NIV delivery using the Theoretical
Domain Framework (TDF) [16]. The TDF was used as a
guiding theory for this project because the desired behav-
ior change is primarily at the individual level, e.g., convin-
cing providers to consider NIV in any patient with severe
COPD exacerbation. We summarized the barriers in the
TDF domains with an eye toward choosing an implemen-
tation strategy which could overcome several of the identi-
fied barriers. Eight of the 14 domains (knowledge, skills,
professional roles and identity, beliefs about capabilities,
beliefs about consequences, environmental context and
resources, social influences, and emotion) were present in
the existing literature and our research.
Interdisciplinary teamwork, on-going education, pro-
viders buy-in, and RTs autonomy were found as the top
four determinants for successful NIV delivery in COPD
exacerbations. These findings suggest that to succeed,
implementation strategies need to account for the com-
plex and interdisciplinary nature of NIV therapy and the
need for team coordination.
Step 3: to guide the selection of implementation strat-
egies, we used the Expert Recommendations for Imple-
menting Change (ERIC) [17]. The main themes that
emerged from the qualitative analysis and literature review
mapped to the TDF domains and the implementation
strategies most likely to address those barriers are shown
in Table 1. Systematic analysis of the barriers suggested
that to succeed, implementation strategies for knowledge
transfer need to account for the complex and interdiscip-
linary nature of the NIV therapy and the need for team
coordination; however, these hypotheses need to be care-
fully tested. Interprofessional, dynamic team training for
physicians, RTs, and nurses was the implementation strat-
egy selected as targeting several key determinants [16, 18,
19].
NIV is delivered in high acuity environments by teams
in which membership is dynamic, decisions must be
made quickly, and members are not always face-to-face
(asynchronously taking care of patients). This creates a
critical need for effective communication, conflict man-
agement, and shared mental model [20] skills that are
well suited to IPE approaches [21–23]. By contrast, con-
ventional education regarding NIV is administered to in-
dividual clinicians or groups of clinicians of the same
discipline via lectures or online modules. Educating indi-
vidual care providers in silos does not address the inter-
professional collaboration inherent to NIV delivery. On
the other hand, IPE competencies emphasize the import-
ance of establishing awareness and knowledge regarding
interprofessional team roles. In this way, leveraging an
IPE platform enables learning via interaction between
two or more professions who learn from, with, and
about each other’s roles and responsibilities (in this case,
in regards to NIV) [24, 25].
The overall objective of this study is to conduct a
pragmatic, parallel, 2-arm randomized cluster trial to
compare the effectiveness of two implementation strat-
egies: on-line education (OLE) and interprofessional
education (IPE) on the uptake of NIV. The central hy-
pothesis is that IPE will outperform conventional educa-
tion, and that RT autonomy and/or team functionality
will act as mediators. We will accomplish this goal by
completing three specific aims.
Aim 1: To compare the effectiveness of OLE and IPE
for increasing the delivery of NIV in appropriate patients
hospitalized with COPD exacerbation.
Aim 2: To examine the effect of OLE and IPE on RT
autonomy and team functionality as potential mediators
of NIV uptake.
Aim 3: To evaluate the acceptability and feasibility of




In this cluster randomized controlled 2-arm parallel trial,
20 hospitals will be randomized to OPE or to IPE. Pa-
tients and clinicians are clustered within the hospitals
because the IPE encourage facility-level change in clini-
cians’ communication and care coordination.
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Hospital recruitment
The study will be conducted in 20 hospitals with risk-
adjusted NIV proportion below median that have at least
35 eligible COPD admissions in an 18-month period. Po-
tential eligible hospitals are those participating with data
in Premier database, a voluntary, fee-supported database
containing highly detailed hospital billing data pooled
from more than 600 geographically and structurally di-
verse hospitals whose makeup closely resembles that of
US hospitals. Hospitals that demonstrate interest in par-
ticipating in the study will be asked to commit to form a
COPD-NIV team composed of one physician, one RT,
and one nurse that will be in close contact with the inves-
tigators and are responsible for delivering the educational
intervention in their institution. Eligible hospitals will be
contacted in a random order until the sample of 20 hospi-
tals is achieved. To assess for potential participation bias,
we will compare participating and refusing hospitals using
available data such as size, ownership, teaching status, and
location. The overall study design is shown in Fig. 3.
The Explanatory Continuum Indicator Summary (PRE-
CIS) framework was used to assess the pragmatism of the
trial (Fig. 4).
Randomization
We will randomly allocate hospitals to one of the study
arms, stratified by the baseline NIV proportion and hos-
pital bed size. A researcher not involved in the study
and blinded to the identity of the hospitals will use a
computer-generated randomization scheme. The
randomization scheme will be concealed to the investi-
gators. Due to the character of the intervention, it will
not be possible to blind participants or investigators pro-
viding the educational program; however, the investiga-
tors will not be aware of the results of the study by
intervention arm until the analysis is finalized.
Implementation strategies
The trial will compare two implementation strategies: one
active control consisting of traditional, online education
Table 1 Themes mapped to theoretical domain framework and implementation strategies
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(OLE) learning and a strategy of in-person interactive
inter-professional education (IPE). Consent for participa-
tion in the educational strategies will be sought as a waiver
of consent via an email sent to all potential participants
after the randomization period and prior to the imple-
mentation at each site. Participants in the COPD-NIV
teams and the training will be physicians, RTs, and nurses
who are involved in treating patients with severe COPD
exacerbation.
The following domains will be targeted in the educa-
tional training interventions:
1. Knowledge: evidence for NIV use, understanding
patient selection, monitoring, and weaning (NIV
algorithm); NIV advantage over IMV (OLE and
IPE)
2. Skills: ability to manage/monitor patients on NIV:
NIV settings, how to attend to patient comfort
(OLE and IPE)
3. Interprofessional collaboration competencies: roles
and responsibilities, teams and teamwork, values
and ethics, and interprofessional communication
(IPE only)
The hospital-based COPD-NIV teams will be respon-
sible throughout the trial period for encouraging clini-
cians from each specialty to complete the courses. The
investigators will have a conference call with the COPD-
Fig. 3 Study flowchart. Key: RS-NIV = Risk Standardized Noninvasive Ventilation, IPE = Interprofessional Education, RT = Respiratory Therapist, OLE
= Online Education, LOS = Length of stay
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Fig. 4 The explanatory continuum indicator summary (PRECIS). Key: RS-NIV rates: Risk Standardized-Noninvasive Ventilation rates, COPD: Chronic
Obstructive Pulmonary Disease, NIV: Noninvasive Ventilation, RT: Respiratory Therapist, IPE: Interprofessional Education
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NIV team after the institutions have been randomized to
discuss recruitment and surveys’ delivery. (e.g., RT Au-
tonomy, team functionality, and organizational readiness
for implementing change). Conference calls between the
investigators and the individual COPD-NIV team will
continue every quarter for the duration of the 18 months
of active implementation period with a follow-up call at
the end of the study.
Active control group: online education (OLE)
Sites will be given access to free continuing education
modules customized for each discipline; RT and nurse
online education training will be approximately 30 min
long, and physician’s online education training will be
about 1 h. The modules will be delivered online through
a secure website that will allow us to count the number
of providers completing the course. We will use trad-
itional PowerPoint presentations with embedded white-
board animation videos. We selected an active control
instead of usual care, because it will allow stronger infer-
ences about the benefits of IPE when compared to more
traditional learning approaches. The online modules will
be offered for the entire period of the study for all the
new staff.
Intervention group: interprofessional education (IPE)
It will consist of a 60-minute in-person interprofessional
educational workshop.
Training of the facilitators We will organized a one
day in-person training for all the NIV-COPD teams. The
training will consist of 2 modules: (1) NIV knowledge
and skills: delivered by NIV experts and (2) IPE: deliv-
ered by an expert in IPE and team training. The didactic
training regarding NIV use in COPD will include a re-
view of the evidence supporting the benefits of NIV, ad-
vantages of NIV as compared to invasive mechanical
ventilation (IMV), selection of patients, contraindica-
tions to NIV, and management of patients while on NIV
including monitoring, ventilator settings, attention to pa-
tient comfort, weaning from NIV, and decision about
NIV failure and need for intubation. The didactic mod-
ule will emphasize the importance of early initiation of
NIV in patients with severe COPD. The second half of
the training will concentrate on teaching interprofes-
sional collaboration. Specifically, the Interprofessional
Education Collaborative (IPEC) recommends four key
competencies in successful IPE, which include roles and
responsibilities, teams and teamwork, values and ethics,
and interprofessional communication [26]. We selected
the following core competencies for our interactive IPE.
Professional roles and identity: each team member learns
about abilities, tasks, duties, responsibilities, and con-
cerns of their fellows’ team members; values/ethics: work
with individuals of other professions to maintain a cli-
mate of mutual respect and shared values; teams/team-
work: apply relationship-building values and the
principles of team dynamics to perform effectively in dif-
ferent team roles to deliver patient-center care that is
safe, timely, effective, and efficient [27]. Given the de-
mands for team coordination in NIV delivery and find-
ings in our qualitative work, we anticipate that IPE will
contribute to greater RT, physician, and nurse under-
standing of each other’s roles, increase team communi-
cation and functionality, and stimulate the development
of shared mental models which facilitate coordination
for NIV. We will use positional clarification which in-
volves verbally presenting team members with informa-
tion about their teammates’ jobs through discussion
[28]. Psychological safety and speaking up will be en-
couraged and facilitated. For example, an RT may as-
sume that physicians have more knowledge about NIV
delivery for a particular patient than they do (because
physicians are generally more knowledgeable about
treatments) and remain quiet; when in fact, the RT has
important information about how the patient may re-
spond (cognitive bias) [29].
The sessions will be recorded, so that participants will
have ongoing access to the content. We anticipate that
the members of the COPD-NIV team who will become
the training facilitators at their hospital will not be sub-
ject matter experts in the training context, especially the
IPE. Therefore, a special instructor script will be written
and will be paired with the presentation.
Delivery of the IPE sessions at institutions randomized
to IPE Training sessions for clinicians at IPE sites will be
led by the COPD-NIV teams and will include information
(e.g., 30-min lecture), demonstration (providers will be
provided with contextualized examples), and practice (30-
min, action-based approach with guided practice). It will
contain a scenario of a patient with severe COPD coming
to the emergency room with shortness of breath. They will
review the guidelines for patient selection and monitoring
and NIV settings and management. Each participant will
be able to try the NIV mask and understand the import-
ance of appropriate settings and attending to patient com-
fort. The three core competencies for interprofessional
collaboration and how they apply to the NIV delivery will
be explained. The IPE sessions will be offered up to twice
a month for 3 months—the number will vary by institu-
tion depending on the number of providers that need to
be trained. For the entire period of the study, we will con-
tinue to have every other monthly breakfast/lunch meet-
ings where cases of patients with COPD in need of NIV
will be presented with emphasis on interprofessional work
structure, RT autonomy, and team functionality. Full IPE
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sessions will be offered once a month every 6 months for
the new staff, as part of on-boarding.
Outcome measures
Table 2 outlines the implementation and effectiveness
outcomes at the cluster (hospital) level, their implemen-




To compare the effectiveness of OLE and IPE for in-
creasing the delivery of NIV in appropriate patients hos-
pitalized with COPD exacerbation.
Primary outcome Hospital-level risk-standardized (RS)
initial NIV proportion among patients hospitalized with
a COPD exacerbation that were ventilated with NIV or
IMV is assessed via administrative records of patients
discharged from participating premier hospital who were
40 years or older and received a principal diagnosis of
COPD, or a principal diagnosis of acute respiratory fail-
ure paired with a secondary diagnosis of COPD. We will
use a previously validated set of ICD-10-CM codes that
achieve a reasonable balance of sensitivity and specificity
while minimizing potential biases [30].
Secondary outcomes RS hospital rates of NIV failure
(IMV after a trial of NIV), mortality, length of stay, and
30-day readmission among all patients with COPD.
Table 2 Outcome measures
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All outcomes will be measured at the hospital level: (1) at
baseline using prior 18 months of data, (2) at 18 months
post-implementation to assess immediate/short term im-
pact, and the following 18 months to assess sustainability.
The 18-month assessment period is necessary to have ad-
equate numbers of eligible COPD admissions for assessing
hospital rates of NIV utilization. The time from
randomization to the completion of the educational ses-
sions with an expected duration of 3 months will not be in-
cluded in the calculation of RS-NIV post-intervention. To
examine penetration, we will measure providers’ exposure
to educational training using participation logs.
Patient and hospital information demographics, co-
morbidities, prior year number of admissions for COPD,
prior year use of NIV or IMV, and outcomes will be
identified from ICD-10 procedure codes and billing
codes. For each participating hospital, we will record the
number of beds, the annual number of admissions for
COPD, teaching status, geographic region, and whether
it serves an urban or rural population. We will also col-
lect information about staffing: number of RTs, hospital-
ists, emergency room physicians, and nurses. We will
record if hospitals use protocols for NIV initiation and
management, and if NIV can be delivered on the regular
medical floor or only in an intensive care unit. These
factors will be used to describe participant hospitals and
evaluated as potential confounders or effect modifiers.
Noninvasive and invasive ventilation For each patient,
we will examine standardized charge codes generated
daily by respiratory therapists as well as dated ICD-10-
procedure codes to determine whether or not they were
treated with assisted ventilation, and, if so, whether ven-
tilation was NIV or IMV. We define the primary method
of ventilation as the first method by date and distinguish
between patients treated with NIV as an initial strategy
from those in whom NIV use follow exposure to invasive
mechanical ventilation (IMV). We have previously vali-
dated the NIV ICD procedure codes and respiratory
therapy charge codes by retrospective medical chart re-
view. Using ICD-9-CM codes alone yielded a sensitivity
of 86% (95% CI, 81–92%) and specificity of 92% (95% CI,
84–98%). The approach of using ICD-9-CM procedure
codes and/or respiratory therapist charges increased sen-
sitivity to 99% (95% CI, 98–4 100%) without reducing
specificity (92%, 95% CI, 84–99%) [31].
Statistical analysis of aim 1 We will generate descrip-
tive statistics overall, by hospital and educational strategy,
including counts and percentages for categorical data,
means, standard deviations, and percentile distributions
for continuous data. We will compare characteristics of
hospitals, including staffing characteristics, in the two
study arms via chi-square tests and t tests or Wilcoxon
tests. Characteristics of patients in the enrolled hospitals in
the two arms will be compared via GEE models accounting
for clustering by hospital. We will calculate the percentage
of patients treated according to each of the primary ventila-
tory strategies: no assisted ventilation, NIV, and IMV. We
will then calculate the proportion of patients initially
treated with NIV among those who received assisted venti-
lation. We will estimate a risk-standardized proportion of
ventilated patients initially treated with NIV (RS-NIV) for
each hospital and for each data collection period (baseline
period, 18 months post-intervention, and between 18 to 36
months post-intervention). We will use hierarchical logistic
regression with a random hospital effect to model initial
use of NIV among patients started on ventilation, adjusting
for demographics, and comorbidities. From the model, a
predicted NIV percentage for each hospital will be com-
puted as the NIV percentage that would be anticipated at a
particular hospital by using its hospital random effect, given
the patient case mix. The expected NIV percentage will be
computed as the rate that would be expected if the same
patient mix were treated at an “average” hospital, using the
average hospital effect. The RS-NIV percentage is then
computed as the ratio of predicted to expected NIV per-
centage standardized by the overall unadjusted mean NIV
percentage for all admissions in our model. Risk
standardization has 2 key advantages: it adjusts for differ-
ences in patient mix, which may impact the suitability of
NIV; it also provides more stabilized estimates based upon
Bayesian shrinkage towards the overall mean among
hospitals with small numbers of ventilated patients
[32, 33]. The mean and median RS-NIV rates of the
two arms will be computed for each study period.
The primary analysis will use an analysis of variance
model to compare IPE to OLE on change in RS-NIV
rates from baseline to 18 months post-intervention.
Additional analyses will adjust for hospital character-
istics that are unbalanced between the study arms. A
secondary analysis will compare the post-intervention
levels, adjusting for baseline RS-NIV. To assess sus-
tainability, similar models will be used to compare
level of RS-NIV after an additional 18 months have
passed.
For the secondary outcomes, our analysis will calculate
hospital RS-rates of NIV failure, mortality, 30-day re-
admission, and length of stay among ventilated patients,
as well as all COPD admissions for each study period.
We will compare outcomes of OLE and IPE hospitals
using models described above. Although we assume that
the patients treated in IPE hospitals will have better clin-
ical outcomes, we do not expect it to be able to detect
an effect of these strategies on secondary outcomes due
to overall low outcome rate, the small projected change,
and relatively small number of clusters.
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Organizational readiness The implementation of the
educational strategies to increase the use of NIV in
COPD exacerbations will require the coordinated action
of many organizational members (e.g., physicians, RTs,
and nurses). The organizational readiness for imple-
menting change (ORIC) survey can assess this construct
at the supra-individual level (team, department, or
organization) [34]. When organizational readiness is low,
clinicians at these hospitals are likely to see the imple-
mentation (educational strategies) for the intervention
(NIV use in COPD exacerbations) as undesirable and
potentially avoid or resist planning for the implementa-
tion or participating in the implementation [34, 35]. The
ORIC will allow us to identify the difference between or-
ganizations resisting the change (increasing NIV
utilization) and sites that are unable to implement the
educational strategies due to difficulties inherent in or-
ganizing and conducting the educational strategies at
their hospital. To assess the readiness of the
organization to implement the change, we will use a 7-
item survey adapted from the original 10-item
organizational readiness for implementing change
(ORIC) [34]. This survey will measure change commit-
ment and change efficacy of the organization towards in-
creasing the rate of NIV use for COPD exacerbations.
Power and sample size for aim 1 The minimal number
of hospitals participating in the trial was based on the ana-
lysis of Premier 2016–2017 data. Hospital RS-NIV propor-
tions were calculated for the 457 hospitals with at least 35
eligible COPD admissions. The median RS-NIV rate
among this group of hospitals was 82% (IQR 74–86%).
We then selected the 48 hospitals with RS-NIV propor-
tion less than 55%, based on the clinical impression that
these hospitals would have sufficient room for improve-
ment, as potentially eligible sites. Among these hospitals,
the median number of eligible COPD patients was 197
over a 12-month period, ranging from 23 to 556 patients.
The number of ventilated patients per hospital ranged
from 7 to 163, with a median of 37. To achieve stability in
estimation of hospital level RS-NIV, we will assess our pri-
mary endpoint at 18 months post-intervention expecting a
minimum of 10 ventilated patients per hospital in which
to assess NIV rates. Power analysis was conducted to de-
termine the number of hospitals needed to assess the pri-
mary outcome of difference between the study arms in
change in the hospital level risk-standardized proportion
of ventilator starts that are NIV (RS-NIV). Using a type I
error rate of 0.05, and standard deviation of change in
rates over time derived from our prior work with the
Premier data base, a total sample of 20 hospitals, 10 in
each arm will give 80% power to detect difference of 15%
in change (e.g., 5% increase among OLE hospitals, vs. 20%
increase among IPE hospitals). Power is > 90% to detect a
20% difference in change between the intervention
groups.
Aim 2
To examine the effect of OLE and IPE on RT autonomy
and team functionality as potential mediators of NIV
uptake.
Study design To complete this aim, we will survey clini-
cians at baseline, 1 year, and end of the study period.
Participants and settings We will select a random sam-
ple of 10 RTs for the RT survey and 21 providers (7
from each discipline) for team functionality and
organizational readiness for change surveys. A waiver of
consent will be sent to all potential participants via
email, the survey link will be included at the end of the
email. To maximize participation, we will provide $25
incentives to participants.
RT autonomy Job autonomy is defined as the degree of
perceived control that an employee has over how they
perform tasks and the degree to which they operate in-
dependently. Prior studies showed that it mediates the
relationship between employment status, work attitude,
and performance [36, 37]. In our previous study, in-
depth interviews with key stakeholders from a sample of
hospitals with high use of NIV suggested that RT auton-
omy is critical to achieving timely initiation of NIV,
often facilitated by the use of protocols [15]. These re-
sults are in line with prior literature [38] that supports
the benefits of autonomous RT practice for weaning
from IMV [39, 40]. Factors identified by the interviewees
to contribute to RT autonomy were RT-driven proto-
cols, RT expertise, and collegial relationship between RT
and physicians. We assume that IPE will increase the
physicians trust in RTs by allowing them to learn about
their abilities and duties and concerns, and that IPE will
facilitate team member recognition of their own know-
ledge with RTs being more likely to “speak up” (e.g., to
suggest NIV use instead of intubation). To assess RT au-
tonomy, we adapted a survey from the 11-item job au-
tonomy measure from Aarons et al [37].
Team functionality The IOM 2001 and 2006 quality
chasm reports brought widespread attention to clinical
teamwork as a means of improving safety and quality in
healthcare [41]. Engagement in training-related activities
designed to disseminate knowledge, skills, and attitudes
for teamwork (such as IPE) is one way to acquire attitudes
and behaviors consistent with teamwork and improve
downstream impact on care quality and safety for patients
[42–44]. get all clinicians (physicians, RTs, and nurses) in-
volved in the delivery of NIV with the goal of promoting
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mutual trust and effective communication which will im-
prove team functionality and hopefully promote NIV use.
To assess team functionality, we adapted questions from
the 4-point Likert scale Assessment of Collaborative En-
vironment survey (ACE-15), a 15-item questionnaire
which measures the perception of interprofessional “team-
ness” [45]. We created an 18-item questionnaire that has
been divided into two parts: the first is the 9-item measure
team functionality in managing patients with COPD ex-
acerbation and the second is the 9–item measure team
functionality in initiating NIV.
Statistical analysis We will develop a series of models
evaluating associations among the intervention, media-
tors, and outcome, including a structural equation model
(SEM) to estimate the role of mediators as well as the
direct effect of intervention on the outcome [46–49].
First, to evaluate the impact of educational intervention
on the mediators RT autonomy and team functionality
to implement change, multi-level models will be fit, clus-
tering on hospital. Additional models will adjust for hos-
pital and practitioner characteristics. Next, models for
the primary RS-NIV outcome will be fit, with these po-
tential mediators as the primary predictors. Main effects
and interaction models will be evaluated. Then, the me-
diators will also be included as covariates in multi-level
models including intervention, to evaluate whether RT
autonomy and team functionality have effects on out-
come, and after controlling for intervention. Finally,
multi-level structural equation modeling will then be
employed to estimate the indirect effect of the educa-
tional intervention on RS-NIV in the presence of media-
tors. Analysis will be performed using STATA’s gsem.
This model will allow estimation of the direct effect of
IPE intervention relative to OLE, in addition to the im-
pact through the mediators (Fig. 5).
Power and sample size for aim 2 For aim 2 analyses,
power was assessed for educational mode impact on job
autonomy for respiratory RT measured by Aaron’s Job
Autonomy Survey (AJAS), and team functionality mea-
sured by the ACE-15 tool. Estimating sample size to
achieve 80% power, using a type I error rate of 0.05, a
sample of 10 RT’s per hospital, will allow us to detect a
moderate (Cohen’s d = .4) difference in AJAS at a 1-year
post-intervention. This is accounting for clustering on
hospital with intraclass correlation (ICC) in the range of
.10–.20. Based upon data from local area hospitals, we
estimate staffing of 8–10 RTs per 100 beds. For a few
smaller hospitals, we will hope to include all RTs and
may fall short of 10. Similarly, for the ACE-15, a sample
size of 21 clinicians (7 each of RTs, RNs, and MDs) will
achieve 80% power to detect a moderate effect size dif-
ference, accounting for clustering within hospitals, with
ICC in the range of .10–.20 [50].
Specific aim 3
To evaluate the acceptability and feasibility of the IPE
and OLE strategies and to inform further refinement of
the strategies.
Study design To achieve this aim, we will perform a
qualitative study using semi-structured interviews with
providers to assess relative importance of various bar-
riers and determinants on the implementation of the
two strategies.
Participants and settings We will recruit a random
sample of nurses, physicians, and RTs. As it is typical in
qualitative research, the total sample is not fixed; de-
pending of the size of the program, we will select 2–4 in-
dividuals from each profession in each hospital and
expect to enroll approximately 40–50 providers enabling
us to reach thematic saturation. Potential participants
will be contacted via email by the study research assist-
ant and invited to conduct an interview. A waiver of
consent will be included in the body of the email prior
to the contact information for the interview. Those who
Fig. 5 Mediation analysis. Key: RT = Respiratory Therapist, NIV = Noninvasive Ventilation
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are interested in participating will be contacted by tele-
phone to arrange an interview time over the telephone. To
maximize participation, we will provide $50 incentives and
schedule sessions at a time convenient to the participants.
Data collection We anticipate that interviews will last
approximately 30 min. All interviews will be audio re-
corded and transcribed verbatim. The interview team will
consist of one research associate who will be trained by
the investigator. The focus of the interviews will be to ex-
plore the implementation process—the acceptability and
feasibility of the educational training strategies, participa-
tion in the training sessions, barriers to participation,
adaptation made to the training sessions, and how the
NIV protocol was incorporated into the clinical workflow.
Expected outcomes This qualitative analysis will allow
us to gain a broader perspective on the process of imple-
mentation from the perspective of the participants. We
expect to understand and identify barriers and facilita-
tors and their relative importance for this implementa-
tion strategy to be the most successful. The knowledge
gained from this aim will be important for further appli-
cation and refinement of IPE for other therapies/inter-
ventions directed to the critically ill patients.
Data analysis Transcripts will be reviewed by the inter-
viewer for accuracy. Qualitative data management and
analysis software (NVivo) will be used to organize and
code the data [51]. The nature of the interviewee role
and the setting in which they work will be summarized
and reported by location. We will use directed qualita-
tive content methods to analyze interview content, be-
ginning with a coding framework based on our prior
work [52, 53]. Coding will occur concurrently with the
interviews to ensure that the interview guide is eliciting
data related to the domains of interest. Two team mem-
bers will be primarily responsible for coding and will be
supervised by one co-investigator proficient in qualita-
tive analysis. The first 2 interviews will be read by each
researcher with the goal of agreeing on the use of the
domains and or constructs. This codebook will be used
for all interviews going forward, with the team meeting
periodically to discuss the emergence of any new codes
or to clarify the relevance of domains and constructs to
the text. Each transcript will be coded twice, once by
each researcher. Discrepancies will be discussed until
consensus is reached. Through regular investigators
meetings, we will generate overarching themes.
Economic evaluation
The investigation will collect the following information
to calculate the costs to initiate the intervention: (1) cost
of the training of the COPD-NIV team in the IPE arm of
the study and inclusive of salary/fringe costs of the im-
plementation specialists travel to the one day training
session, (2) cost of webinars inclusive of speaker costs
and video recording costs, and (3) cost of the continuing
educational credits provided to the clinicians attending
the IPE sessions at their hospitals and to the COPD-NIV
team for their attendance of the 1-day session and for
teaching the COPD-NIV-IPE course at their hospital.
Dissemination
We propose the following strategies for dissemination:
(1) after study completion, we will host webinars to
share the results with the participant hospitals; (2) we
will develop a one-page information sheet with the re-
sults and conclusion of the study and distribute it on the
Premier Inc. website; (3) we will develop a toolkit and
implementation manual with step-by-step guidance to
help other institutions implement the IPE strategy; (4)
publications and presentations at national and inter-
national respiratory and D&I conferences; and (5) we
will work with Society of Hospital Medicine and COPD
foundation to share the finding of the study to their
members.
Table 3 present the proposed timeline for the study.
Potential limitation and rational for key decisions
Why study only education?
We have carefully considered other implementation
strategies such as audit and feedback, which is an elec-
tronic medical records decision support tool and aca-
demic detailing. When mapping the barriers within
ERIC compilation of implementation strategies, we
found that IPE covered several of identified barriers.
Additionally, we were concern that using multiple strat-
egies would complicate our attempt to understand the
educational intervention impact. Interprofessional care is
essential to the management of seriously ill patients and
in the absence of robust studies to determine if IPE in-
deed impact patient outcomes, it is critical to be able to
assess it in randomized controlled trial.
Why limit the trial to Premier hospitals?
For this pragmatic clinical trial, we need to be able to cal-
culate hospitals’ NIV rates and identify low performing
hospitals to be able to invite them to participate in the
trial and determine the rates after the implementation
period. Our intention was to have these rates calculated
directly from the administrative or electronic data without
a need for data collection. We did not come across any
other database which provides the needs for this trial.
Still, if the trial shows that IPE is effective in improving
the NIV rates, individual hospitals will be able to calculate
their own rates and decide if they want to implement the
IPE strategy.
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Discussion
This study will be among the first to carefully test the
impact of IPE in the inpatient setting. Over the last 20
years, there have been increasing interest in linking IPE
with interprofessional collaboration and team-based care
[26, 54]; however, only recently have researchers begun
to look beyond the classroom and beyond learning out-
comes on such issues as patient safety, patient and
provider satisfaction or quality, and cost of care. Conse-
quently, the 2015 Institute of Medicine Report “Measur-
ing the impact of interprofessional education on
collaborative practice and patient outcomes” questions
calls for purposeful, well-designed, robust studies to
understand the link between IPE and patient and health
systems outcomes [55]. Therefore, our study will add to
the evidence by comparing an IPE strategy specifically
designed to improve team functionality for NIV delivery
in a pragmatic randomized controlled trial against an ac-
tive, realistic control.
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